GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Eli Lilly and Co (LSE:LEL) » Definitions » Other Stockholders Equity

Eli Lilly and Co (LSE:LEL) Other Stockholders Equity : $-3,013 Mil (As of Dec. 2023)


View and export this data going back to . Start your Free Trial

What is Eli Lilly and Co Other Stockholders Equity?

Eli Lilly and Co's Other Stockholders Equity for the quarter that ended in Dec. 2023 was $-3,013 Mil.

Eli Lilly and Co's quarterly Other Stockholders Equity stayed the same from Jun. 2023 ($-3,013 Mil) to Sep. 2023 ($-3,013 Mil) but then increased from Sep. 2023 ($-3,013 Mil) to Dec. 2023 ($-3,013 Mil).

Eli Lilly and Co's annual Other Stockholders Equity stayed the same from Dec. 2021 ($-3,013 Mil) to Dec. 2022 ($-3,013 Mil) and stayed the same from Dec. 2022 ($-3,013 Mil) to Dec. 2023 ($-3,013 Mil).

Eli Lilly and Co Other Stockholders Equity Historical Data

The historical data trend for Eli Lilly and Co's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Eli Lilly and Co Other Stockholders Equity Chart

Eli Lilly and Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Stockholders Equity
Get a 7-Day Free Trial Premium Member Only Premium Member Only -3,013.20 -3,013.20 -3,013.20 -3,013.20 -3,013.20

Eli Lilly and Co Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3,013.20 -3,013.20 -3,013.20 -3,013.20 -3,013.20

Eli Lilly and Co Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

Eli Lilly and Co Other Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Eli Lilly and Co's Other Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Eli Lilly and Co (LSE:LEL) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Eli Lilly and Co (LSE:LEL) » Definitions » Other Stockholders Equity
Comparable Companies
JNJ MRK ABBV AMGN PFE BMY GILD BIIB OGN AMRN LSE:AZN XSWX:NOVN XSWX:ROG XPAR:SAN LSE:GSK TSE:4568 TSE:4519 SHSE:600276 XTER:BAYN TSE:4578
Traded in Other Exchanges
LLY:USA LLY:Mexico 1LLY:Italy LLY:Germany LLY:Switzerland LLY:Canada LILY34:Brazil LLYC:Austria LLY:Argentina
Address
Lilly Corporate Center, Indianapolis, IN, USA, 46285
Website
https://www.lilly.com
Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for diabetes; and Taltz and Olumiant for immunology.

Eli Lilly and Co (LSE:LEL) Headlines

No Headlines